최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국호스피스·완화의료학회지 = Korean journal of hospice and palliative care, v.20 no.3, 2017년, pp.159 - 166
According to the advance of antiretroviral regimen and the early treatment strategy, people living with human immunodeficiency virus (PLWH) are achieving the goal of virologic suppression and immune restoration. Most of them no more die of acquired immunodeficiency syndrome (AIDS) defining illnesses...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
HIV 질환은 어떤 증상을 유발하는가 | 감염인 환자 진료의 초기단계부터 HIV 질환 자체에 대한 치료와 함께 삶의 질을 개선하기 위한 완화치료를 위한 계획의 수립의 병행이 필요하다. 감염인들은 통증, 피로와 위약감, 체중감소, 식욕부진, 발열, 오심, 구토, 설사, 변비, 호흡곤란, 피부소양증, 욕창, 신경계 문제, 섬망, 우울증 등 정신과적인 증상의 다양한 증상들을 호소하며 각각에 대한 원인 감별과 질병 특이 치료와 함께 완화적 치료의 병행이 필요하다(19). 본 종설에서는 통증과 뇌신경계 문제를 예시로 다루어 보고자 한다. | |
후천면역결핍증의 특징은 무엇인가 | 1984년 그 원인 병원체가 인간면역결핍바이러스(human immunodeficiency virus, 이하 HIV)라는 것이 알려진 지 33년이 되었다(3). 마땅한 치료제가 알려지기 전까지 HIV에 의해 발생하는 후천면역결핍증(acquired immunodeficiency syndrome, AIDS)은 특히 젊은 사람들에게 발생하여, 급속히 환자를 사망에 이르게 하는 질환으로, 위중한 기회감염증의 존재 여부가 예후의 결정과 치료에 매우 중요하였다. 의사들은 고통과 죽음의 과정에 있는 환자들의 증상을 경감시키기 위해 노력했었고, 이들을 정서적으로 지지하고, 죽음과 배제와 낙인에 직면할 수 있도록 돕는 경험들을 하였다고 한다(4). | |
HIV 감염 환자를 돌봄에 있어서 감염인의 완화 의료를 실행하기 어렵게 만드는 조건은 무엇인가 | 2) 호스피스 돌봄의 제공: UNAIDS (The Joint United Nations Programme on HIV and AIDS)에서는 감염인 환자를 돌봄에 있어 HIV 감염이 갖는 복잡한 질병 경과, 치료과정, 사회적 낙인과 차별, 복잡한 가족문제, 가족 내역할의 변화, 간호간병 인력이 겪게 되는 스트레스 부담 등이 감염인의 완화의료를 실행하기 어렵게 만드는 조건이라고 지적하였다(33). 이 문제들 중 치료과정과 질병 경과의 호전을 제외한 나머지 사항들은 현재도 여전히 문제가 된다. |
Centers for Disease Control (CDC). Pneumocystis pneumonia-Los Angeles. MMWR Morb Mortal Wkly Rep 1981;30:250-2.
Centers for Disease Control (CDC). Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men-New York City and California. MMWR Morb Mortal Wkly Rep 1981;30: 305-8.
Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868-71.
Selwyn PA, Arnold R. From fate to tragedy: the changing meanings of life, death, and AIDS. Ann Intern Med 1998;129: 899-902.
United States. Department of Health and Human Services; Centers for Disease Control and Prevention (U.S.); Panel on Clinical Practices for the Treatment of HIV Infection (U.S.). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents [Internet]. [Atlanta, GA]: [U.S. Dept. of Health and Human Services, Centers for Diseases Control and Prevention (CDC)]; 2016. Available from: https://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL003412.pdf.
INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 2015;373:795-807.
TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, et al. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. N Engl J Med 2015;373:808-22.
Kim SW. Non-AIDS morbidity among HIV patients. Korean J Med 2016;90:487-93.
Centers for Disease Control & Prevention. 2017 HIV/AIDS control guidelines [Internet]. Cheongju: Centers for Disease Control & Prevention; 2016. Available from: https://www.cdc.go.kr/CDC/cms/content/mobile/81/72281_view.html.
UNAIDS. UNAIDS DATA 2017 [Internet]. Geneva: UNAIDS; c2017. Available from: http://www.unaids.org/sites/default/files/media_asset/20170720_Data_book_2017_en.pdf.
Costagliola D. Demographics of HIV and aging. Curr Opin HIV AIDS 2014;9:294-301.
Sobrino-Vegas P, Moreno S, Rubio R, Viciana P, Bernardino JI, Blanco JR, et al. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013. J Infect 2016;72:587-96.
National Human Rights Commission of Korea. 2017 Medical discrimination survey on people living with HIV/AIDS. Seoul: National Human Rights Commission of Korea;2016.
Stewart A, Chan Carusone S, To K, Schaefer-McDaniel N, Halman M, Grimes R. Causes of Death in HIV Patients and the Evolution of an AIDS Hospice: 1988-2008. AIDS Res Treat 2012;2012:390406.
Selwyn PA, Rivard M. Palliative care for AIDS: challenges and opportunities in the era of highly active anti-retroviral therapy. J Palliat Med 2003;6:475-87.
Kay ES, Batey DS, Mugavero MJ. The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future. AIDS Res Ther 2016;13:35.
Mahajan AP, Sayles JN, Patel VA, Remien RH, Sawires SR, Ortiz DJ, et al. Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS 2008;22 Suppl 2:S67-79.
Pressian.com [Internet]. AIDS patients can not go to any hospitals. Who are responsible? Seoul: Pressian Coop.; 2016 Jan 30. Available from: http://www.pressian.com/news/article.html?no132875.
Yennurajalingam S, Bruera E. Oxford American handbook of hospice and palliative medicine and supportive care. 2nd ed. Oxford;New York:Oxford University Press;2016. p. 407-18.
Carr DB. Pain in HIV/AIDS a major global healthcare problem [Internet]. Washington, D.C.: International Association for the Study of Pain; c2017. Available from: https://www.iasp-pain. org/files/Content/ContentFolders/GlobalYearAgainstPain2/20042005RighttoPainRelief/paininhivaids.pdf.
Almeida MV, Seal PS, Clark RA. Challenges in the management of chronic pain in HIV/AIDS. HIV Clin 2014;26:12-5.
Schutz SG, Robinson-Papp J. HIV-related neuropathy: current perspectives. HIV AIDS (Auckl) 2013;5:243-51.
Merlins JS, Tucker RO, Saag MS, Selwyn PA. The role of palliative care in the current HIV treatment era in developed countries. Top Antivir Med 2013;21:20-6.
Bowen LN, Smith B, Reich D, Quezado M, Nath A. HIVassociated opportunistic CNS infections: pathophysiology, diagnosis and treatment. Nat Rev Neurol 2016;12:662-74.
Matinella A, Lanzafame M, Bonometti MA, Gajofatto A, Concia E, Vento S, et al. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study. J Neurol 2015;262:1317-27.
Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 2010;9:425-37.
Fournier A, Martin-Blondel G, Lechapt-Zalcman E, Dina J, Kazemi A, Verdon R, et al. Immune reconstitution inflammatory syndrome unmasking or worsening AIDS-related progressive multifocal leukoencephalopathy: a literature review. Front Immunol 2017;8:577.
Arentzen M, Jubt F, Evers S, Hesselmann V, Fiori W, Reichelt D, et al. Cerebrovascular events in HIV-infected patients: an analysis of a cohort of 3203 HIV+ patients during the times of cART. Int J Neurosci 2015;125:601-11.
Stuart B. The NHO Medical Guidelines for Non-Cancer Disease and local medical review policy: hospice access for patients with diseases other than cancer. Hosp J 1999;14:139-54.
Local Coverage Determination (LCD) for Hospice - HIV Disease (L31535) [Internet]. Chicago, IL; American Medical Association: c2002-2012. Available from: file:///C:/Users/Yoo/Downloads/Palmetto%20HIV.pdf.
Korean Academy of Medical Sciences. Definitions of the end stage of disease and the last days of life and medical guidance on them. Seoul:Korean Academy of Medical Sciences;2016.
Fox E, Landrum-McNiff K, Zhong Z, Dawson NV, Wu AW, Lynn J. Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. JAMA 1999; 282:1638-45.
AIDS: Palliative Care: UNAIDS Technical Update [Internet]. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2000. Available from: http://apps.who.int/medicinedocs/en/d/Jh2930e/2.html.
Kojima Y, Iwasaki N, Yanaga Y, Tanuma J, Koizumi Y, Uehira T, et al. End-of-life care for HIV-infected patients with malignancies: A questionnaire-based survey. Palliat Med 2016; 30:869-76.
Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, et al. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol 2013;34:875-92.
Choi JY. Updates on preventing HIV infection. Korean J Med 2016;90:474-80.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.